NanoViricides, Inc. the Company , is a nano biopharmaceutical company whose business goals are to discover, develop and commercialize therapeutics to advance the care of patients suffering from life threatening viral infections. We are a development stage company with several drugs in various stages of early development.
Quote | NanoViricides Inc. (NYSE:NNVC)
Last: | $1.78 |
---|---|
Change Percent: | 0.54% |
Open: | $1.84 |
Close: | $1.78 |
High: | $1.88 |
Low: | $1.74 |
Volume: | 208,535 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | NanoViricides Inc. (NYSE:NNVC)
SHELTON, CT / ACCESSWIRE / July 1, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its current assets and plans towards becoming a successful pharmaceutical company intending to revolutioni...
--News Direct-- NanoViricides CEO Dr Anil Diwan joined Steve Darling from Proactive to share promising news about the company's ultra-broad-spectrum antiviral, NV-387. The antiviral was found to be effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse mod...
Message Board Posts | NanoViricides Inc. (NYSE:NNVC)
Subject | By | Source | When |
---|---|---|---|
Companys Broad-Spectrum Antiviral NV-387 Has Demonstrated Excellent Effectiveness | drkazmd65 | investorshub | 07/11/2023 2:43:07 PM |
We're up almost to $1.60 (it was briefly | drkazmd65 | investorshub | 07/11/2023 2:36:58 PM |
Thanks for the thoughts. | loanranger | investorshub | 07/10/2023 9:33:09 PM |
It's impossible to know the exact details of | KMBJN | investorshub | 07/10/2023 4:37:50 PM |
what does this mean? | arvitar | investorshub | 07/10/2023 11:56:22 AM |
News, Short Squeeze, Breakout and More Instantly...
SHELTON, CT / ACCESSWIRE / July 1, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its current assets and plans towards becoming a successful pharmaceutical company intending to revolutioni...
--News Direct-- NanoViricides CEO Dr Anil Diwan joined Steve Darling from Proactive to share promising news about the company's ultra-broad-spectrum antiviral, NV-387. The antiviral was found to be effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse mod...
SHELTON, CT / ACCESSWIRE / June 24, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, comments that the ultra-broad-spectrum antiviral NV-387 could be an important weapon against bird flu H5N1 viruses. Nan...